4D Molecular Therapeutics, Inc. financial data

Symbol
FDMT on Nasdaq
Location
Emeryville, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 10 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1082% % -52%
Debt-to-equity 12% % 63%
Return On Equity -47% % -69%
Return On Assets -42% % -62%
Operating Margin -507678% % -93113%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 49,778,127 shares 50%
Common Stock, Shares, Outstanding 46,771,185 shares -10%
Entity Public Float $1,044,134,011 USD 66%
Common Stock, Value, Issued $5,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 56,126,330 shares 1%
Weighted Average Number of Shares Outstanding, Diluted 56,126,330 shares 1%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $37,000 USD -100%
Revenue from Contract with Customer, Excluding Assessed Tax $120,000 USD 567%
General and Administrative Expense $49,326,000 USD 12%
Operating Income (Loss) $230,379,000 USD -37%
Nonoperating Income (Expense) $21,202,000 USD -15%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $209,177,000 USD -46%
Earnings Per Share, Basic -3 USD/shares -35%
Earnings Per Share, Diluted -3 USD/shares -35%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $48,555,000 USD -74%
Marketable Securities, Current $256,508,000 USD -18%
Assets, Current $312,377,000 USD -39%
Property, Plant and Equipment, Net $16,153,000 USD -19%
Operating Lease, Right-of-Use Asset $18,907,000 USD -13%
Other Assets, Noncurrent $9,380,000 USD 228%
Assets $423,982,000 USD -30%
Accounts Payable, Current $6,863,000 USD 135%
Employee-related Liabilities, Current $9,120,000 USD -5.1%
Accrued Liabilities, Current $24,189,000 USD 13%
Contract with Customer, Liability, Current $360,000 USD 929%
Liabilities, Current $37,107,000 USD 26%
Contract with Customer, Liability, Noncurrent $835,000 USD -35%
Operating Lease, Liability, Noncurrent $16,568,000 USD -16%
Other Liabilities, Noncurrent $144,000 USD -27%
Liabilities $54,999,000 USD 7.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax $671,000 USD -38%
Retained Earnings (Accumulated Deficit) $735,701,000 USD -40%
Stockholders' Equity Attributable to Parent $368,983,000 USD -33%
Liabilities and Equity $423,982,000 USD -30%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $47,758,000 USD -64%
Net Cash Provided by (Used in) Financing Activities $318,832,000 USD 2800%
Net Cash Provided by (Used in) Investing Activities $31,948,000 USD
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 46,771,185 shares -10%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $15,810,000 USD -160%
Deferred Tax Assets, Valuation Allowance $128,084,000 USD 9%
Deferred Tax Assets, Gross $133,733,000 USD 9.1%
Operating Lease, Liability $22,263,000 USD -10%
Depreciation $5,100,000 USD 6.2%
Payments to Acquire Property, Plant, and Equipment $631,000 USD -11%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $209,585,000 USD -47%
Lessee, Operating Lease, Liability, to be Paid $29,021,000 USD -15%
Property, Plant and Equipment, Gross $36,216,000 USD 2.4%
Operating Lease, Liability, Current $5,695,000 USD 12%
Lessee, Operating Lease, Liability, to be Paid, Year Two $5,350,000 USD -4.5%
Lessee, Operating Lease, Liability, to be Paid, Year One $5,601,000 USD -0.66%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6,758,000 USD -27%
Lessee, Operating Lease, Liability, to be Paid, Year Three $5,510,000 USD 3%
Deferred Tax Assets, Operating Loss Carryforwards $72,385,000 USD 22%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $7,078,000 USD -41%
Lessee, Operating Lease, Liability, to be Paid, Year Four $5,675,000 USD 3%
Operating Lease, Payments $1,400,000 USD 75%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $24,042,000 USD -1.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%